U.S. flag

An official website of the United States government

NM_000548.5(TSC2):c.4638C>T (p.Ala1546=) AND not specified

Germline classification:
Benign (4 submissions)
Last evaluated:
Oct 30, 2017
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000125691.22

Allele description [Variation Report for NM_000548.5(TSC2):c.4638C>T (p.Ala1546=)]

NM_000548.5(TSC2):c.4638C>T (p.Ala1546=)

Gene:
TSC2:TSC complex subunit 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_000548.5(TSC2):c.4638C>T (p.Ala1546=)
Other names:
p.A1546A:GCC>GCT; p.Ala1546Ala
HGVS:
  • NC_000016.10:g.2085298C>T
  • NG_005895.1:g.40993C>T
  • NM_000548.5:c.4638C>TMANE SELECT
  • NM_001077183.3:c.4437C>T
  • NM_001114382.3:c.4569C>T
  • NM_001318827.2:c.4329C>T
  • NM_001318829.2:c.4293C>T
  • NM_001318831.2:c.3906C>T
  • NM_001318832.2:c.4470C>T
  • NM_001363528.2:c.4440C>T
  • NM_001370404.1:c.4506C>T
  • NM_001370405.1:c.4509C>T
  • NM_021055.3:c.4509C>T
  • NP_000539.2:p.Ala1546=
  • NP_001070651.1:p.Ala1479=
  • NP_001107854.1:p.Ala1523=
  • NP_001305756.1:p.Ala1443=
  • NP_001305758.1:p.Ala1431=
  • NP_001305760.1:p.Ala1302=
  • NP_001305761.1:p.Ala1490=
  • NP_001350457.1:p.Ala1480=
  • NP_001357333.1:p.Ala1502=
  • NP_001357334.1:p.Ala1503=
  • NP_066399.2:p.Ala1503=
  • LRG_487t1:c.4638C>T
  • LRG_487:g.40993C>T
  • NC_000016.9:g.2135299C>T
  • NM_000548.3:c.4638C>T
  • NM_000548.4:c.4638C>T
  • p.A1546A
  • p.(=)
Links:
Tuberous sclerosis database (TSC2): TSC2_00958; dbSNP: rs45517354
NCBI 1000 Genomes Browser:
rs45517354
Molecular consequence:
  • NM_000548.5:c.4638C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001077183.3:c.4437C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001114382.3:c.4569C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001318827.2:c.4329C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001318829.2:c.4293C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001318831.2:c.3906C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001318832.2:c.4470C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001363528.2:c.4440C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001370404.1:c.4506C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001370405.1:c.4509C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_021055.3:c.4509C>T - synonymous variant - [Sequence Ontology: SO:0001819]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000169155GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Benign
(Oct 31, 2013)
germlineclinical testing

Citation Link,

SCV000305228PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benigngermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000967123Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(Feb 21, 2013)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002066262Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Oct 30, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot provided11not providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GeneDx, SCV000169155.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From PreventionGenetics, part of Exact Sciences, SCV000305228.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000967123.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Ala1546Ala in exon 36 of TSC2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 1.3% (59/4392) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs45517354).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

From Genetic Services Laboratory, University of Chicago, SCV002066262.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024